ARIXTRA 2.5 mg/0.5 ml, solution for injection in a pre-filled syringe 10 syringes of 0.5 ml
Active ingredients: FONDAPARINUX SODIQUE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 syringes of 0.5 mlintraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ARIXTRA 2,5 mg/0,5 ml, solution injectable en seringue pré-remplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse;sous-cutanée
- Presentation description
- 10 seringue(s) préremplie(s) en verre de 0,5 ml avec aiguille(s)
- Marketing authorisation holder
- VIATRIS HEALTHCARE (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 15 May 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64683217CIP75636197CIP133400956361977Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FONDAPARINUX SODIQUEsolution | 2,5 mg · une seringue pré-remplie de 0,5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.